Obtaining reimbursement for new spine surgery technology isn't a walk in the park. There are instances where a new technology receives FDA clearance, support from spine societies, a Category 1 CPT code and coverage by Medicare and Medicaid, and a number of articles detailing clinical evidence supporting use of the technology is published, yet commercial insurance companies still question the procedure.
Stryker plans to acquire Synergetics USA's neuro portfolio.
Research from Finn Partners shows patients are becoming a more vital part of healthcare economics, as reported in Drug Store News. They are more educated consumers and aren't afraid to cost- and quality-compare for their care.
A new study published in the Journal of Spinal Disorders and Techniques examines adjacent segment degeneration and disease after lumbar spinal fusion.
Ellipse Technologies withdrew its initial public offering yesterday, according to a Renaissance Capital report.
A surgical technician is suing the surgeon who allegedly hit him in the operating room during a 2014 pediatric brain surgery, according to a Connecticut Law Tribune report.
A new study published in Spine examines injuries and hospital outcomes for spinal fracture patients with ankylosing spondylitis.
Amedica is now in compliance with NASDAQ listing requirements after a period last year where the company's share price dipped below $1.
Implanet hired Brian T. Ennis as president of Implanet America.
Compounding creams to treat pain are the target of a new big Justice Department investigation after allegations emerged that companies sent out more product than was ordered, overbilled and automatically refilled prescriptions without being asked. And, to some of the creams reportedly have little or no medical value, according to a report in Nasdaq.